Danaher DHR
NYSE DHR
$212.54 +4.18 (+2.01%)
As of: Sep 17, 2026 · 3:59 PM EDT

Danaher (DHR) Cash from Investing Activities (2009 - 2026)

Danaher (DHR) posted Cash from Investing Activities of -$10.1 billion for Q2 2026, down 3975.1% on a QoQ basis from -$249.0 million in Q1 2026, and down 3832.95% year-over-year from $271.8 million in Q2 2025.

Analysis

Danaher (DHR) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Danaher has reported Cash from Investing Activities for 18 years, with the latest figure at -$10.1 billion in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities fell 3832.95% year-over-year to -$10.1 billion in Q2 2026; TTM through Jun 2026 was -$11.1 billion, a 516.22% decrease from a year earlier, with the FY2025 full-year figure at -$1.2 billion, up 39.63% from the prior year.
  • Cash from Investing Activities was -$10.1 billion for Q2 2026 at Danaher, down from -$249.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$242.0 million in Q1 2025, with the low at -$10.1 billion in Q2 2026.
  • Average Cash from Investing Activities over 5 years is -$1.3 billion, with a median of -$392.0 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities soared 94.87% in 2022, then sank 3832.95% in 2026.
  • Over 5 years, Cash from Investing Activities stood at -$816.0 million in 2022, then tumbled by 637.38% to -$6.0 billion in 2023, then jumped by 88.47% to -$694.0 million in 2024, then soared by 44.67% to -$384.0 million in 2025, then sank by 2542.45% to -$10.1 billion in 2026.
  • The last three Cash from Investing Activities figures came in at -$10.1 billion (Q2 2026), -$249.0 million (Q1 2026), and -$384.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 164.00 Mn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -10.15 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -1.03 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -122.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -3.51 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -7.06 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -66.70 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -2.09 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -7.74 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -25.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 26, 2026 -10.15 Bn
Mar 27, 2026 -249.00 Mn
Dec 31, 2025 -384.00 Mn
Sep 26, 2025 -312.00 Mn
Jun 27, 2025 -258.00 Mn
Mar 28, 2025 -242.00 Mn
Dec 31, 2024 -694.00 Mn
Sep 27, 2024 -606.00 Mn
Jun 28, 2024 -360.00 Mn
Mar 29, 2024 -321.00 Mn
Dec 31, 2023 -6.02 Bn
Sep 29, 2023 -329.00 Mn
Jun 30, 2023 -431.00 Mn
Mar 31, 2023 -304.00 Mn
Dec 31, 2022 -816.00 Mn
Sep 30, 2022 -515.00 Mn
Jul 1, 2022 -400.00 Mn
Apr 1, 2022 -503.00 Mn
Dec 31, 2021 -879.00 Mn
Oct 1, 2021 -10.05 Bn